Investonomics
Contributor since: 2013
Latest Articles
BlueLinx: A Turnaround Story With Strong Business Moat
Advanced Emissions Solutions: A Strong Energy Play On Offer
Zumiez: An Apparel Stock You Need To Avoid
Can SpaceX Build A Sustainable Business Model Amidst Resounding Challenges?
Changing Healthcare Dynamics Make AIRM A Strong Buy
Oasmia Pharmaceutical: Commercial Clearance In Russia Could Pave The Way To Europe And The U.S.
Medigus: Disruption In The Global GERD Market In The Making
Synta - Madrigal Merger: Is There A Potential Value Play Here?
Accenture Outshines Peers In Burgeoning Market
AbbVie Is A Buy Despite Humira Exclusivity Loss
Exxon Mobil Executing A Long Play On Fossil Fuels
7 Reasons To Avoid Chevron
Akamai's Impressive Cloud Connectivity And Security Solutions Make It A Compelling Buy
Verisk Analytics Is A Buy For Long-Term Value Investors
Visa: This Buffett Portfolio Pick Deserves A Place In Your Portfolio
A. Schulman's Agenda For Growth Marred By Lucent Risk
Cancer Prevention Pharma IPO: Riding The Biopharma Wave
Westlake Chemical: Value Proposition For The Texan Chemical Major
Fundamental Strengths And Relative Mis-Pricing Provide A Long Opportunity Into Global Sources
Long Term Intrinsic Factors Make Assured Guaranty A Compelling Buy
Tempur Sealy: There Is More To It Than Meets The Eye
Hooker Furniture: Rebound In Progress Amidst Challenging Surroundings
Ally Financial: Allay Your Fears
Why An Android Powered Device Might Just Backfire For Microsoft
Alibaba: This IPO Is Going To Be A Roller Coaster Ride
American Express: A Fundamentally Driven Stock With A Potential 38% Upside
AFC Enterprises: Recent Events And Near-Term Catalysts Present An Attractive Opportunity
ZaZa Energy: Strengthen Your Portfolio With This Compelling Value Play
Bank Of Nova Scotia Offers A Compelling Opportunity With 38% Upside
Low Risk And High Organic Growth Prospects Make TD Bank A Compelling Value Play
AIG: A Great Turnaround Story, And What Comes Next For The Global Insurance Giant